Independent Franchise Partners
US Equity Fund
US Equity Fund Portfolio 13F
Independent Franchise Partners Holdings Activity
- Portfolio value:
- $1.59B≈ (-$287M≈)
- Previous value:
- $1.87B≈
- # of changes:
- 29
- New positions:
- 0
- Reported for:
- 30 Jun 2022 (Q2)
- Latest filing date:
- 26 Aug 2022
US Equity Fund has disclosed a total of 29 changes to the portfolio in the (2022 Q2) SEC report(s): increased the number of shares of 3, decreased the number of shares of 25 and completely sold out 1 position(s).
What did Independent Franchise Partners invest in during 2022 Q2?
In the 2022 Q2 report(s) the following changes have been made to the top investments: (BMY) Bristol-Myers Squibb Company (reduced shares -16.13%), (PM) Philip Morris International Inc (reduced shares -2.27%), (NVSEF) Novartis AG (reduced shares -2.26%), (RBA) RB Global Inc (reduced shares -2.26%) and (FOXA) Fox Corp, CL-A (reduced shares -2.27%).
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.